- Home
- POAI vs CELZ Comparison
POAI vs CELZ Comparison
Compare POAI & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- CELZ
- Stock Information
- Founded
- POAI 2002
- CELZ 1998
- Country
- POAI United States
- CELZ United States
- Employees
- POAI N/A
- CELZ N/A
- Industry
- POAI Industrial Specialties
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- CELZ Health Care
- Exchange
- POAI Nasdaq
- CELZ Nasdaq
- Market Cap
- POAI 4.9M
- CELZ 4.7M
- IPO Year
- POAI N/A
- CELZ N/A
- Fundamental
- Price
- POAI $0.71
- CELZ $2.38
- Analyst Decision
- POAI Hold
- CELZ
- Analyst Count
- POAI 1
- CELZ 0
- Target Price
- POAI N/A
- CELZ N/A
- AVG Volume (30 Days)
- POAI 98.3K
- CELZ 23.0K
- Earning Date
- POAI 11-12-2024
- CELZ 11-08-2024
- Dividend Yield
- POAI N/A
- CELZ N/A
- EPS Growth
- POAI N/A
- CELZ N/A
- EPS
- POAI N/A
- CELZ N/A
- Revenue
- POAI $1,484,223.00
- CELZ $11,000.00
- Revenue This Year
- POAI N/A
- CELZ N/A
- Revenue Next Year
- POAI $569.48
- CELZ N/A
- P/E Ratio
- POAI N/A
- CELZ N/A
- Revenue Growth
- POAI N/A
- CELZ N/A
- 52 Week Low
- POAI $0.55
- CELZ $2.12
- 52 Week High
- POAI $3.76
- CELZ $10.28
- Technical
- Relative Strength Index (RSI)
- POAI 47.04
- CELZ 35.64
- Support Level
- POAI $0.69
- CELZ $2.12
- Resistance Level
- POAI $0.80
- CELZ $2.50
- Average True Range (ATR)
- POAI 0.06
- CELZ 0.19
- MACD
- POAI -0.01
- CELZ 0.02
- Stochastic Oscillator
- POAI 25.93
- CELZ 26.55
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.